VARIZIG (Cangene BioPharma)
Welcome to the PulseAid listing for the VARIZIG drug offered from Cangene BioPharma. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Cangene BioPharma |
| NON-PROPRIETARY NAME: | Varicella Zoster Immune Globulin (Human) |
| SUBSTANCE NAME: | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-05-22 |
| END MARKETING DATE: | 0000-00-00 |
VARIZIG PLASMA DERIVATIVE Details:
| Item Description | VARIZIG from Cangene BioPharma |
| LABELER NAME: | Cangene BioPharma |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.25([iU]/mL) |
| START MARKETING DATE: | 2015-05-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53270-0126_1743d54c-b53e-4a93-9bcb-41caf047fc10 |
| PRODUCT NDC: | 53270-0126 |
| APPLICATION NUMBER: | BLA125430 |
Other HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
